Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin.
Adolescent
Adult
Aged
Aged, 80 and over
Anticoagulants
/ adverse effects
Atrial Fibrillation
/ complications
Factor Xa Inhibitors
/ adverse effects
Female
Humans
Male
Middle Aged
Proportional Hazards Models
Retrospective Studies
Rivaroxaban
/ adverse effects
Stroke
/ diagnosis
Warfarin
/ adverse effects
Young Adult
atrial fibrillation
mortality
rivaroxaban
stroke
warfarin
Journal
Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
1
1
2020
medline:
1
7
2020
entrez:
1
1
2020
Statut:
ppublish
Résumé
Background and Purpose- Oral anticoagulation therapy is standard of care for patients with nonvalvular atrial fibrillation to prevent stroke. This study compared rivaroxaban and warfarin for stroke and all-cause mortality risk reduction in a real-world setting. Methods- This retrospective cohort study (2011-2017) included de-identified patients from the Optum Clinformatics Database who started treatment with rivaroxaban or warfarin within 30 days following initial diagnosis of nonvalvular atrial fibrillation. Before nonvalvular atrial fibrillation diagnosis, patients had 6 months of continuous health plan enrollment and CHA
Identifiants
pubmed: 31888412
doi: 10.1161/STROKEAHA.119.025554
pmc: PMC7004448
doi:
Substances chimiques
Anticoagulants
0
Factor Xa Inhibitors
0
Warfarin
5Q7ZVV76EI
Rivaroxaban
9NDF7JZ4M3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
549-555Références
N Engl J Med. 2003 Sep 11;349(11):1019-26
pubmed: 12968085
PLoS One. 2014 Feb 10;9(2):e88225
pubmed: 24520356
J Am Coll Cardiol. 2019 Jul 9;74(1):104-132
pubmed: 30703431
J Clin Epidemiol. 2015 Nov;68(11):1292-300
pubmed: 25700940
J Atr Fibrillation. 2016 Feb 29;8(5):1279
pubmed: 27909470
Thromb Haemost. 2016 Sep 28;116(Suppl. 2):S13-S23
pubmed: 27623681
N Engl J Med. 2013 Nov 28;369(22):2093-104
pubmed: 24251359
J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2054-2059
pubmed: 25113085
Curr Med Res Opin. 2016 Dec;32(12):2047-2053
pubmed: 27633045
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
J Am Heart Assoc. 2017 Oct 28;6(11):
pubmed: 29080863
N Engl J Med. 2011 Sep 8;365(10):883-91
pubmed: 21830957
J Am Heart Assoc. 2016 Mar 08;5(3):e002197
pubmed: 26955859
Stroke. 2014 Dec;45(12):3754-832
pubmed: 25355838
Circulation. 2015 Jan 13;131(2):157-64
pubmed: 25359164
Stud Health Technol Inform. 2014;202:115-8
pubmed: 25000029
J Epidemiol. 2017 Jan;27(1):24-29
pubmed: 28135194
Neurology. 1999 Jul 13;53(1):126-31
pubmed: 10408548
J Am Coll Cardiol. 2018 Mar 6;71(9):1048-1049
pubmed: 29495985
Heart Rhythm. 2016 Aug;13(8):1581-8
pubmed: 27033342
Curr Cardiol Rev. 2014 Nov;10(4):297-302
pubmed: 24821657
Lancet Neurol. 2012 Apr;11(4):315-22
pubmed: 22402056
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
JAMA. 2017 Mar 14;317(10):1057-1067
pubmed: 28291892
Neuroepidemiology. 2013;40(4):227-39
pubmed: 23364221
Stroke. 2018 Dec;49(12):2933-2944
pubmed: 30571400
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Lancet. 2014 Mar 15;383(9921):955-62
pubmed: 24315724
AMIA Annu Symp Proc. 2017 Feb 10;2016:799-807
pubmed: 28269876